跳至主要内容
临床试验/NCT03296891
NCT03296891已完成不适用

Randomized Point of Care Ultrasound Guided Resuscitation and Usual Care Comparison in the Management of Undifferentiated Shock: a Pilot Study

Western University, Canada2 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2017年9月10日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
50
试验地点
2
主要终点
Recruitment rate

研究概览

简要总结

This project aims to determine the feasibility of conducting a randomized controlled trial investigating point of care ultrasound guided resuscitation compared with usual care in the management of shock at the Critical Care Trauma Centre (CCTC) in London Health Science Centre (LHSC).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients deemed by the clinician to be in shock for any reason and has 3 out of 4 of the following:
  • Lactate greater than or equal to 2.2 mmol/L
  • AKIN stage I or greater or Urine output less than 0.5 cc/hr
  • Altered level of consciousness due to shock or requiring invasive mechanical ventilation as a result of shock
  • Vasoactive agents required to maintain a mean arterial pressure greater than 65 mmHg.

排除标准

  • Pregnant patients
  • Participants who have already undergone a PoCUS study (as defined in the protocol for this study) within the past 48 hours
  • Participants who have restrictions on their goals of care at the time of ICU admission (including patients refusing blood products).
  • Patients post cardiac arrest who are not obeying commands

结局指标

主要结局

Recruitment rate

时间窗: averaged over 48 week period (active recruitment taking place in 48 of those 52 weeks)

Number of patients who were successfully enrolled in the study per given week.

次要结局

  • Revoked deferred consent rate(28 days)
  • Cumulative fluid balance(7 days)
  • Protocol adherence rate(28 days)
  • Vasoactive medication free days(28 days)
  • Contamination rate(28 days)
  • Ventilator free days(28 days)
  • Acute Kidney Injury (AKIN) stage(7 days)
  • Mortality(28 days)
  • Successful randomization rate(28 days)
  • ICU length of stay(28 days)
  • Continuous renal replacement therapy free days(28 days)

研究者

发起方
Western University, Canada
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验